Neurology
- FDA Panels Recommend Approval of Abuse-Deterrent IR Oxycodone
- Suicide Risk Doubles After Concussion
- New Drug Option Fails for Rare Polio-Like Virus in Kids
- High BP in Young Adults a Harbinger of Premature CVD, Death
- Intensive Patient Education Fails to Ease Low Back Pain
- No Mortality Risk for Parkinson's With Normal Cognition
- FDA Rejects IV Opioid Painkiller Oliceridine
- Repeated CBD Doses Required for Effective Pain Relief
- Culturally Tailored Stroke Education Lowers BP in Secondary Stroke Prevention
- CSF Testing May Rapidly Identify Cause of Neurologic Symptoms
- Appendix Removal Linked to Lower Future Parkinson's Risk
- Higher Serum Cortisol in Midlife Tied to Impaired Memory
- Erenumab for Migraine: Results Published
- Hospitalization Linked to Dementia-Related Brain Changes
- A Novel Treatment Approach for PML
- CHMP Backs Antiarrhythmic for Muscle-Contraction Disorders
- ECTRIMS 2018 Novel Anti-B-Cell Therapy Looks Promising in MS
- Cannabinoids Mildly Effective for Multiple Sclerosis Symptoms
- Gabapentin May Top Pregabalin for Sciatica Pain
- Positive Topline Results for Migraine Drug in Two Safety Studies